Literature DB >> 29353367

Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry.

Tarsha Jones1, Debra Duquette2, Meghan Underhill3, Chang Ming4, Kari E Mendelsohn-Victor5, Beth Anderson6, Kara J Milliron7, Glenn Copeland8, Nancy K Janz9, Laurel L Northouse5, Sonia M Duffy10, Sofia D Merajver9,11, Maria C Katapodi12,13.   

Abstract

PURPOSE: This study examined clinical breast exam (CBE) and mammography surveillance in long-term young breast cancer survivors (YBCS) and identified barriers and facilitators to cancer surveillance practices.
METHODS: Data collected with a self-administered survey from a statewide, randomly selected sample of YBCS diagnosed with invasive breast cancer or ductal carcinoma in situ younger than 45 years old, stratified by race (Black vs. White/Other). Multivariate logistic regression models identified predictors of annual CBEs and mammograms.
RESULTS: Among 859 YBCS (n = 340 Black; n = 519 White/Other; mean age = 51.0 ± 5.9; diagnosed 11.0 ± 4.0 years ago), the majority (> 85%) reported an annual CBE and a mammogram. Black YBCS in the study were more likely to report lower rates of annual mammography and more barriers accessing care compared to White/Other YBCS. Having a routine source of care, confidence to use healthcare services, perceived expectations from family members and healthcare providers to engage in cancer surveillance, and motivation to comply with these expectations were significant predictors of having annual CBEs and annual mammograms. Cost-related lack of access to care was a significant barrier to annual mammograms.
CONCLUSIONS: Routine source of post-treatment care facilitated breast cancer surveillance above national average rates. Persistent disparities regarding access to mammography surveillance were identified for Black YBCS, primarily due to lack of access to routine source of care and high out-of-pocket costs. IMPLICATIONS: Public health action targeting cancer surveillance in YBCS should ensure routine source of post-treatment care and address cost-related barriers. Clinical Trials Registration Number: NCT01612338.

Entities:  

Keywords:  Adherence; Clinical breast exam; Mammography; Out-of-pocket-cost; State cancer registry

Mesh:

Year:  2018        PMID: 29353367     DOI: 10.1007/s10549-018-4674-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  2 in total

1.  Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations.

Authors:  Pierre O Chappuis; Maria C Katapodi; Chang Ming; Valeria Viassolo; Nicole Probst-Hensch; Ivo D Dinov
Journal:  Br J Cancer       Date:  2020-06-22       Impact factor: 7.640

2.  Assessing Perceived Discrimination as Reported by Black and White Women Diagnosed with Breast Cancer.

Authors:  Arnethea L Sutton; Nao Hagiwara; Robert A Perera; Vanessa B Sheppard
Journal:  J Racial Ethn Health Disparities       Date:  2020-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.